Diethylstilbestrol in utero exposure and cancers risk, 2011
From Maryland – Exposure to Diethylstilbestrol in the womb raises a woman’s risk of many cancers, according to a report published in the New England Journal of Medicine. Researchers studied over 6500 women, 4600 of whom were exposed to DES in the womb. Results showed that this exposure significantly increased risk of many cancers and fertility problems, including a 40x increased risk of clear-cell adenocarcinoma, 8x increased risk of neonatal death, 2.4x increased risk of infertility and a 1.8x increased risk of breast cancer.
DES Daughter Susan Helmrich is one of the best swimmers in the world in her age group
Susan Helmrich is one of the best swimmers in the world in her age group. She’s also a three-time cancer survivor and a victim of one of the greatest drug tragedies in history. With luck, determination, great medical care, the support of family and friends and the benefits of the sport of swimming, Susan has fought to escape the deadly legacy of a supposed wonder drug turned nightmare.
According to a large study, DES, the anti-miscarriage drug used in the USA until 1971 but also used in Australia and many European countries well after 1971, has been linked to health problems — including breast cancer, infertility, difficult pregnancies and early menopause — in the daughters and the granddaughters of women who took it.
Want to know more about the pregnancy drug DiEthylStilbestrol?
New AFSSAPS DES survey and update DES historical facts, current issues, risks associated with DES exposure, breast cancer risks, post adolescent psychiatric disorders, risks for the 3rd generation, DES pregnancy care.
DES Sons Numbers and Health Concerns Although less is known about the consequences of diethylstilbestrol exposure in men than in women, important DES health concerns have been identified.
DES Sons Studies The most common reported health issues in DES sons studies are epididymal cysts, testicular problems, testicular cancer, infertility, psychological and neurological effects.
Gender Identity and DES Exposure Dr. Dana Beyer radio interview on the significant evidence linking prenatal Diethylstilbestrol DES exposure with gender identity and transsexual development.